Press/Media
- 50 - 75 out of 115 results
Search results
-
MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD
2/11/21 → 20/12/21
186 items of Media coverage
Press/Media: Research › Popular
-
Zo ga je gelukkig het nieuwe jaar in
20/12/21
2 Media contributions
Press/Media: Public Engagement › Popular
-
Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) to C
16/12/21
1 item of Media coverage
Press/Media: Research › Popular
-
Seksleven verbeteren? Zo raak je samen seksueel opgewonden
16/12/21
1 Media contribution
Press/Media: Public Engagement › Popular
-
Potential $3 Trillion Healthcare Tech Transformation Underway
16/12/21
2 items of Media coverage
Press/Media: Research › Popular
-
Choices of hospitals in times of crisis; what does it do to the staff?
13/12/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
Transgender people continue to face high burden of HIV worldwide
1/12/21 → 10/12/21
25 items of Media coverage
Press/Media: Research › Popular
-
Hersenstimulatie lijkt het geheugen te verbeteren. Wie profiteert van deze breindoping?
10/12/21
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
Study Finds Hallucinogenic Ayahuasca Tea Trip Matches That of Placebo
Malin Uthaug
1/12/21
1 item of Media coverage
Press/Media: Research › Popular
-
Verändern Impfungen den Zyklus der Periode? Stand der Forschung: Möglicherweise
1/12/21
1 item of Media coverage
Press/Media: Research › Popular
-
Hybride, online, op de campus: flexibiliteit is het motto
Sjoerd Claessens, Thomas Cleij, Petra Hurks, Giselle Bosse, Jascha de Nooijer & Mark Vluggen
1/12/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
Mensen met hiv ervaren meer stigma in zorgsector
30/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
New Study of Ayahuasca Users Shows Placebo Effect in Action
Malin Uthaug
29/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
Μια ανώδυνη ιατρική μέθοδος υπόσχεται θεραπεία της κατάθλιψης χωρίς αντικαταθλιπτικά
27/11/21
1 item of Media coverage
Press/Media: Research › Popular
-
Nog even en we trippen onze trauma's weg
24/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
Intranasal Ketamine Garnering A lot of Attention as an Effective Treatment For Depression
22/11/21 → 24/11/21
62 items of Media coverage
Press/Media: Public Engagement › Popular
-
With the Obesity Epidemic Bursting at the Seams, This Could Help
24/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
22/11/21
2 items of Media coverage
Press/Media: Public Engagement › Popular
-
3 Psychedelic Stocks for Potential Out-of-This-World Gains
18/11/21
2 items of Media coverage
Press/Media: Public Engagement › Popular
-
De toekomst van medicinale mdma ziet er in Nederland veelbelovend uit
18/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
Roma, al Maxxi «Emotions»: sette studiose spiegano i legami fra scienza, arte e bellezza
17/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
Form 6-K Mind Medicine (MindMed) For: Nov 16
16/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
MindMed Q3 Earnings: Big Improvement, Kicks Off Sleep & Cognitive Study With Dose Low-Dose LSD
16/11/21
2 items of Media coverage
Press/Media: Public Engagement › Popular
-
Gay, Bisexual Men Have Lower Suicide Risk in More Tolerant Countries
10/11/21 → 16/11/21
4 items of Media coverage
Press/Media: Public Engagement › Popular
-
Mind Medicine begins recruitment for LSD sleep study
16/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular